Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Pulmonary Arterial Hypertension
Related studies linked through entity extraction aliases.
Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
[18F]FES PET/CT in PAH
- Status
- TERMINATED
- Phase
- N/A
Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension
- Status
- WITHDRAWN
- Phase
- PHASE4
Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
- Status
- COMPLETED
- Phase
- PHASE4
LenusPro Pump in PAH Treated With Treprostinil
- Status
- UNKNOWN
- Phase
- N/A
Contribution of Echocardiography to Prognostic Evaluation of Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- N/A
Crossover Study From Macitentan or Bosentan Over to Ambrisentan
- Status
- TERMINATED
- Phase
- PHASE4
An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension
- Status
- WITHDRAWN
- Phase
- PHASE4
MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- N/A
Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID)
- Status
- COMPLETED
- Phase
- PHASE4
Study of Cardiac MRI in the Follow up Assessment of Patients With PAH (EVITA)
- Status
- COMPLETED
- Phase
- NA
TReatment Of Pulmonary HYpertension 1-US Study
- Status
- UNKNOWN
- Phase
- NA
Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension
- Status
- COMPLETED
- Phase
- N/A
3D Imaging: Prognostic Role in Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- N/A
HYPID (Pulmonary Hypertension in Interstitial Lung Disease) EXTENSION
- Status
- COMPLETED
- Phase
- N/A
Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension
- Status
- WITHDRAWN
- Phase
- PHASE3
Right Ventricular Metabolism in Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- N/A
Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585
- Status
- COMPLETED
- Phase
- PHASE1
Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
- Status
- TERMINATED
- Phase
- PHASE2